Advanced
methodologies, such as hyperthermia and modulation of
reactive oxygen species (ROS), exhibit considerable promise in the
therapeutic landscape of cancer. These strategies offer a targeted
paradigm for combating malignant cells while mitigating damage to
healthy tissue. Noteworthy among these approaches is the utilization
of superparamagnetic iron oxide nanoparticles, which are renowned
for their ability to enhance both hyperthermia and ROS generation
specifically within tumor microenvironments. The objective of this
investigation is to scrutinize the relationship between the reaction
duration and the characteristics of carbon-doped silica core–shell
iron oxide nanoparticles (CSIONPs). Specifically, we focus on CSIONP-12,
CSIONP-24, and CSIONP-36, synthesized by using varying reaction periods.
Through a comprehensive analysis, we primarily evaluate the impact
of these formulations on T1 and T2 magnetic resonance imaging (MRI),
aiming to elucidate their mechanisms and therapeutic potential in
promoting hyperthermia and ROS-mediated cancer therapy. CSIONP-24
emerges as a compelling candidate due to its dual influence on magnetic
hyperthermia and ROS generation, suggesting its promise in enhancing
cancer treatment outcomes. Furthermore, the findings underscore the
exceptional T1–T2 MRI capabilities of this technology, underscoring
its versatility and efficacy in the nuanced realm of cancer theranostic.